The Queen's Medical Center, originally named and still commonly referred to as Queen's Hospital, is the largest private non-profit hospital in Honolulu, Hawaii. The institution was founded in 1859 by Queen Emma and King Kamehameha IV, and is located in Downtown Honolulu.

There are 575 beds in Queen's Medical Center.

During the past decade, Queen's Medical Center conducted 206 clinical trials. In the 10-year time frame, 206 clinical trials started and 144 clinical trials were completed, i.e. on average, 69.9% percent of trials that started reached the finish line to date. In the past 5 years, 81 clinical trials started and 97 clinical trials were completed. i.e. 119.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 122 trials, followed by "SWOG Cancer Research Network" with 43 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 27 trials sponsored. Other sponsors include 129 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 140 trials as a collaborator, "NRG Oncology" with 44 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator. Other collaborators include 112 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Queen's Medical Center" are "HIV Infections" (39 trials), "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials) and "Recurrent Breast Carcinoma" (9 trials). Many other conditions were trialed in "Queen's Medical Center" in a lesser frequency.

Most popular intervention types in "Queen's Medical Center" are "Drug" (266 trials), "Other" (178 trials), "Biological" (94 trials), "Procedure" (66 trials) and "Radiation" (57 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (74 trials), "Questionnaire Administration" (48 trials), "Paclitaxel" (37 trials) and "Carboplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "Queen's Medical Center" are 297 trials for "All" genders, 67 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Queen's Medical Center". undefined are not yet recruiting, 69 are recruiting, 142 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 134 completed trials in Queen's Medical Center, 7 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's Medical Center, 12 "Phase 1" clinical trials were conducted, 153 "Phase 2" clinical trials and 173 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 43 trials that are defined as “Not Applicable".

Queen's Medical Center has several departments that took part in Clinical trials: "Queen's Cancer Center - Kuakini" - 148 trials, "Queen's Cancer Institute at Queen's Medical Center" - 60 trials